These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 26012156)
21. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction. Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140 [TBL] [Abstract][Full Text] [Related]
22. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients. Taylor PJ; Kubler PA; Lynch SV; Allen J; Butler M; Pillans PI Ann Pharmacother; 2004 Feb; 38(2):205-8. PubMed ID: 14742751 [TBL] [Abstract][Full Text] [Related]
23. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
26. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation. Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219 [TBL] [Abstract][Full Text] [Related]
27. Switch to an everolimus-facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipients. Kälble F; Seckinger J; Schaier M; Morath C; Schwenger V; Zeier M; Sommerer C Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28581202 [TBL] [Abstract][Full Text] [Related]
28. Severe colchicine intoxication in a renal transplant recipient on cyclosporine. Garrouste C; Philipponnet C; Kaysi S; Enache I; Tiple A; Heng AE Transplant Proc; 2012 Nov; 44(9):2851-2. PubMed ID: 23146540 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of everolimus with reduced-exposure cyclosporine in de novo kidney transplant patients at increased risk for efficacy events: analysis of a randomized trial. Carmellini M; Garcia V; Wang Z; Vergara M; Russ G J Nephrol; 2015 Oct; 28(5):633-9. PubMed ID: 25708913 [TBL] [Abstract][Full Text] [Related]
30. A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients. Bara C; Dengler T; Hack MA; Ladenburger S; Lehmkuhl HB Transplant Proc; 2013; 45(6):2387-92. PubMed ID: 23953553 [TBL] [Abstract][Full Text] [Related]
31. [Drug-induced pneumonitis due to sirolimus: an interaction with atorvastatin?]. Paris A; Goupil F; Kernaonet E; Foulet-Rogé A; Molinier O; Gagnadoux F; Lebas FX Rev Mal Respir; 2012 Jan; 29(1):64-9. PubMed ID: 22240222 [TBL] [Abstract][Full Text] [Related]
32. [Modern immunosuppression following renal transplantation. Standard or tailor made?]. Budde K; Giessing M; Liefeldt L; Neumayer HH; Glander P Urologe A; 2006 Jan; 45(1):9-17. PubMed ID: 16328215 [TBL] [Abstract][Full Text] [Related]
33. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635 [TBL] [Abstract][Full Text] [Related]
34. Conversion to everolimus in kidney transplant recipients: to believe or not believe? Cotovio P; Neves M; Santos L; Macário F; Alves R; Mota A Transplant Proc; 2012 Dec; 44(10):2966-70. PubMed ID: 23195007 [TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation. Batista F; Auyanet I; Torregrosa JV; Oppenheimer F Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461 [TBL] [Abstract][Full Text] [Related]
36. Immunosuppression Modification by Everolimus With Minimization of Calcineurin Inhibitors Recovers Kidney Graft Function Even in Patients With Very Late Conversion and Also With Poor Graft Function. Nojima M; Yamada Y; Higuchi Y; Shimatani K; Kanematsu A; Yamamoto S Transplant Proc; 2017; 49(1):41-44. PubMed ID: 28104155 [TBL] [Abstract][Full Text] [Related]